Sort
39,280 grants matching “leukemia”
Peptide-directed protocells and virus-like particles-new nanoparticle platforms f
$361,400Cheryl L Willman · University Of New Mexico Health Scis Ctr · U01 · FY2010 · CA
Ikaros regulation: study on hemo-lymphopoiesis
$361,396Katia Georgopoulos · Massachusetts General Hospital · R01 · FY2012 · CA
Dietary and Lifestyle Determinants of Colon Cancer Recurrence and Survival
$361,381Charles S Fuchs · Dana-Farber Cancer Inst · R01 · FY2011 · CA
Crosstalk between leukemic blasts and the BM microenvironment contribute to leukemic transformation
$361,374Adrienne M. Dorrance · Utah State Higher Education System--University Of Utah · R01 · FY2025 · CA
New perspective on MyoD function and differentiation in rhabdomyosarcoma
$361,369Denis C Guttridge · Medical University Of South Carolina · R01 · FY2021 · CA
Adminstrative Core
$361,356Ronald Hoffman · Icahn School Of Medicine At Mount Sinai · P01 · FY2007 · CA
Mycophenylate mofetil for treatment of chronic GVHD
$361,338Paul J Martin · Fred Hutchinson Cancer Research Center · R01 · FY2007 · CA
AKT Signaling and Oxidative Stress Regulation of Erythropoiesis
$361,327Saghi Ghaffari · Icahn School Of Medicine At Mount Sinai · R01 · FY2012 · DK
AKT Signaling and Oxidative Stress Regulation of Erythropoiesis
$361,327Saghi Ghaffari · Icahn School Of Medicine At Mount Sinai · R01 · FY2011 · DK
Gene Therapy Clinical Trials for Chronic Granulomatous Disease
$361,326Elizabeth Kang · National Institute Of Allergy And Infectious Diseases · ZIA · FY2016 · AI
Role of the pre-T cell receptor in lineage commitment
$361,298Harald Von Boehmer · Dana-Farber Cancer Inst · R01 · FY2010 · AI
Polymorphism of Multi-Drug-Resistance Protein-1
$361,284University Of Washington · R01 · FY2003 · GM
IGF/IGF1R signaling in hematopoiesis and leukemogenesis
$361,282Zhe Li · Brigham And Women'S Hospital · R01 · FY2014 · HL
Genetic Analysis of H2B Ubiquitylation in Yeast
$361,268Mary Ann Osley · University Of New Mexico Health Scis Ctr · R01 · FY2012 · GM
Defining the role of a novel E3 ubiquitin ligase in V(D)J recombination
$361,250Patrick C. Swanson · Creighton University · R56 · FY2011 · AI
Project 1: Molecular Pathogenesis and Therapy of Myelofibrosis
$361,246Ross L Levine · Icahn School Of Medicine At Mount Sinai · P01 · FY2021 · CA
Project 1: Molecular Pathogenesis and Therapy of Myelofibrosis
$361,246Ross L Levine · Icahn School Of Medicine At Mount Sinai · P01 · FY2020 · CA
Role of TIF1y in Erythropoiesis
$361,207Leonard I Zon · Boston Children'S Hospital · P01 · FY2010 · HL
Genetic Approaches to Hemoglobin Switching
$361,202Stuart H Orkin · Boston Children'S Hospital · P01 · FY2010 · HL
Stopping Tyrosine Kinase Inhibitors in CML Patients (Stop-TKIs)
$361,156Ehab L Atallah · Medical College Of Wisconsin · R01 · FY2019 · CA
Doxorubicin cardiotoxicity and the protective effects of exercise
$361,119Ashley Smuder · University Of Florida · R01 · FY2023 · HL
Induction of Anti-Tumor Immunity after HC Transplant
$361,114Robert Jon Soiffer · Dana-Farber Cancer Inst · U19 · FY2006 · AI
DEVELOPMENTAL FUNDS
$361,086Riccardo Dalla-Favera · Columbia University Health Sciences · P30 · FY2009 · CA
Role of Dok-1 in oncogenic tyrosine kinase signaling
$361,050Linda Van Aelst · Cold Spring Harbor Laboratory · R01 · FY2010 · CA
Role of c-Cbl in Colon cancer
$361,050Vipul C Chitalia · Boston Medical Center · R01 · FY2016 · CA